Arkadios Wealth Advisors reduced its position in shares of SPDR S&P 400 Mid CapGrowth ETF (NYSEARCA:MDYG – Free Report) by ...
Stifel Financial Corp. (NYSE: SF) will release its fourth quarter and full year 2024 financial results before the market opens on Wednesday, January 29, 2025. The company will host a conference call ...
Fintel reports that on January 8, 2025, Stifel initiated coverage of Altimmune (NasdaqGM:ALT) with a Buy recommendation. Analyst Price Forecast Suggests 204.19% Upside As of December 23, 2024, the ...
In the latest quarter, 5 analysts provided ratings for Stifel Financial SF, showcasing a mix of bullish and bearish perspectives. The table below provides a concise overview of recent ratings by ...
Stifel initiated coverage of Edgewise Therapeutics (EWTX) with a Hold rating and $30 price target The firm says that while Edgewise has “very ...
Stifel analyst Tore Svanberg lowered the firm’s price target on On Semiconductor (ON) to $60 from $72 and keeps a Hold rating on the shares ...
According to Evaluate Pharma, China's growing influence in pharmaceutical R&D is a key theme to watch in 2025. The pharma ...
Stifel Financial (SF ... the KBW Nasdaq Capital Markets Index (Index Ticker: KSX, ETF Ticker:N/A), KBW Nasdaq Financial Technology Index (Index Ticker: K CorpGov would like to provide video ...